DANIEL TELEGA: Open Payments
NPI 1669719720 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$52,304 in 325 payments from 12 companies in 2025. Trend: 2023 $14,603 · 2024 $32,064 · 2025 $52,304
Speaker / faculty: $29,425Honoraria: $14,125Food & beverage: $6,083Travel & lodging: $2,671
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 80 | $31,976 |
| Axsome Therapeutics, Inc. | 50 | $17,051 |
| Teva Pharmaceuticals USA, Inc. | 64 | $856 |
| Otsuka America Pharmaceutical, Inc. | 25 | $438 |
| Neurocrine BioSciences, Inc. | 20 | $422 |
| Vanda Pharmaceuticals Inc. | 13 | $364 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $329 |
| E.R. Squibb & Sons, L.L.C. | 21 | $283 |
| Alkermes, Inc. | 15 | $270 |
| Janssen Pharmaceuticals, Inc | 10 | $160 |
Products named: VRAYLAR, Auvelity, UZEDY, INGREZZA, REXULTI, AUSTEDO XR, CAPLYTA, FANAPT.
Industry payments across PA — which companies pay providers there.
